Literature DB >> 3794339

Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies.

H Kubagawa, L F Bertoli, J C Barton, W J Koopman, J Mestecky, M D Cooper.   

Abstract

To determine the extent of clonal involvement of the secretory immune system and the origin of salivary immunoglobulins (Ig) in monoclonal gammopathy patients, saliva and serum samples were collected from five affected individuals (two IgA myelomas, one IgG myeloma, one IgG benign monoclonal gammopathy, and one IgM lymphoma) and were assayed for the presence of monoclonal Ig. Purified polyclonal or monoclonal anti-idiotype (Id) antibodies were prepared against each of the isolated serum paraproteins. In all five individuals, the patient saliva samples inhibited the binding of 125I-labeled homologous Ig to the corresponding anti-Id antibodies, but normal saliva did not. The concentration of Id in patients' saliva varied from 1 to 400 micrograms/ml; i.e., 0.004 to 1.0% of the corresponding serum values. Saliva of a lymphoma patient whose IgM kappa protein exhibited rheumatoid factor (RF) activity also contained RF. The salivary Id-bearing molecules were found to have the same Ig isotype as the serum paraproteins. The myeloma IgA represented a minor component (0.4 and 3.9%) of the total salivary IgA. The salivary IgA myeloma proteins were associated at least in part with secretory component, but the salivary IgG paraproteins were not. In an IgA myeloma patient, a minority (17%) of the IgA+ plasma cells found in the lacrymal gland biopsy specimen were Id+, whereas the great majority (98%) of bone marrow IgA plasma cells were Id+. The results suggest active transport rather than passive transudation of myeloma IgA into the patients' saliva, and the integrity of the secretory immune system was not compromised by the neoplastic process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3794339

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 2.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

3.  Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma.

Authors:  Yu-Hsiang Lee; Jae Hoon Kim; Hui Zhou; Bo Wook Kim; David T Wong
Journal:  J Mol Med (Berl)       Date:  2011-11-18       Impact factor: 4.599

4.  Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.

Authors:  C Lue; A W van den Wall Bake; S J Prince; B A Julian; M L Tseng; J Radl; C O Elson; J Mestecky
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  Studies on the origin and composition of IgA in rat tears.

Authors:  J V Peppard; P C Montgomery
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

6.  Induction of compartmentalized B-cell responses in human tonsils.

Authors:  M Quiding-Järbrink; G Granström; I Nordström; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

7.  Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans.

Authors:  R C Monteiro; H Kubagawa; M D Cooper
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

8.  Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection.

Authors:  Michael W Russell; Zina Moldoveanu; Pearay L Ogra; Jiri Mestecky
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

9.  Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques.

Authors:  Neeltje van Doremalen; Jyothi N Purushotham; Jonathan E Schulz; Myndi G Holbrook; Trenton Bushmaker; Aaron Carmody; Julia R Port; Claude K Yinda; Atsushi Okumura; Greg Saturday; Fatima Amanat; Florian Krammer; Patrick W Hanley; Brian J Smith; Jamie Lovaglio; Sarah L Anzick; Kent Barbian; Craig Martens; Sarah Gilbert; Teresa Lambe; Vincent J Munster
Journal:  bioRxiv       Date:  2021-01-11

10.  Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity.

Authors:  Cyrielle Holuka; Chantal J Snoeck; Sophie B Mériaux; Markus Ollert; Rejko Krüger; Jonathan D Turner
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.